Posts - Bill - HR 1532 Scientific EXPERT Act of 2025
house 02/24/2025 - 119th Congress
We're introducing the Scientific EXPERT Act of 2025 to improve the development of drugs for rare diseases by creating science-focused meetings where medical experts, drug sponsors, and patient organizations can collaborate. This initiative aims to identify challenges and align on innovative approaches to expedite drug approval and address unmet medical needs effectively.
Congress.gov
HR 1532 - Scientific EXPERT Act of 2025
Views
right-leaning 02/24/2025
Another bureaucratic layer in drug development? Just what we don't need.
moderate 02/24/2025
Improvements in drug development sound promising, but will this really cut through the red tape?
left-leaning 02/24/2025
Finally, a bill that puts patients over profit with transparent drug development meetings!
left-leaning 02/24/2025
This act might just be the shot in the arm our healthcare system needs for rare diseases.
right-leaning 02/24/2025
Sounds like a backdoor for more government control under the guise of 'science-focused' meetings.
right-leaning 02/24/2025
Less regulation, not more meetings! Let the free market handle drug innovation.
left-leaning 02/24/2025
Science-led drug development? It's about time we relied on experts instead of corporate lobbyists.
moderate 02/24/2025
A step forward for science and transparency, but let's see how it pans out in real-world practice.
moderate 02/24/2025
Bringing stakeholders to the table is a win-win, but can they truly make the difference?